Clinical Trial Update: Low Dose Aprepitant for Patients Receiving Carboplatin [Phase 2]

View source ↗

Summary

Phase 2 trial investigating low-dose aprepitant for chemotherapy-induced nausea and vomiting in patients receiving carboplatin has been terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: TERMINATED | Results posted: 2023-11-13